Search - tctmd.com

Displaying 41 - 60 of 151

Sort: Relevancy | Date

News Conference News SCAI 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

L.A. McKeown

May 21, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Conference News ISET 2023

The PE Pipeline: Evidence Trickles in for Catheter-Based Therapies

Caitlin E. Cox

January 23, 2023

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Todd Neale

October 19, 2022

Presentation TCT 2022

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

Presenter: Teresa Carman

September 19, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Daily News

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

Todd Neale

March 07, 2022

News Daily News

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

Yael L. Maxwell

February 15, 2022

Presentation TCT 2021

What About Anticoagulation Alone?

Presenter: Teresa Carman

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Connie Hess

November 06, 2021

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Todd Neale

November 03, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for October 2021

Shelley Wood

November 02, 2021

Advertisement

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

What’s Going to Be Hot at ACC/WCC 2023?

The PE Pipeline: Evidence Trickles in for Catheter-Based Therapies

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE

Anticoagulation Strategies in High-Risk PE: Are DOACs Enough? When Do We Switch?

FLASH: More Data to Support Mechanical Thrombectomy in PE

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

TCTMD’s Top 10 Most Popular Stories for August 2022

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

More Support for Single Antiplatelet Therapy After TAVI

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

Antithrombotics Not Worth the Risk During Endovascular Stroke Therapy

No Increased Bleeding With Alteplase in Stroke Patients on DOACs: Registry Data

What About Anticoagulation Alone?

Oral Anticoagulation Should Be the Default Strategy After LAAC

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

TCTMD’s Top 10 Most Popular Stories for October 2021

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content